Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8317656 | Clinical Biochemistry | 2013 | 8 Pages |
Abstract
Presence of these novel ERE-binding proteins in a breast carcinoma is a strong predictor of poor prognosis. Our results suggest that ERE-BP, identified as Ku70/Ku80, in cytosols prepared from breast carcinoma biopsies are useful biomarkers for assessing risk of breast cancer recurrence.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Traci L. Kruer, Timothy D. Cummins, David W. Powell, James L. Wittliff,